APA (7th ed.) Citation

Z, A., W, H., SO, A., J, Y., R, C., S, G., . . . O, N. (2026). Safety and Tolerability of CAR T-Cell Therapy in Patients With End-Stage Kidney Disease on Hemodialysis: A Case Series. Clinical lymphoma, myeloma & leukemia, 26(4), 249. https://doi.org/10.1016/j.clml.2026.01.015

Chicago Style (17th ed.) Citation

Z, Ahmed, et al. "Safety and Tolerability of CAR T-Cell Therapy in Patients With End-Stage Kidney Disease on Hemodialysis: A Case Series." Clinical Lymphoma, Myeloma & Leukemia 26, no. 4 (2026): 249. https://doi.org/10.1016/j.clml.2026.01.015.

MLA (9th ed.) Citation

Z, Ahmed, et al. "Safety and Tolerability of CAR T-Cell Therapy in Patients With End-Stage Kidney Disease on Hemodialysis: A Case Series." Clinical Lymphoma, Myeloma & Leukemia, vol. 26, no. 4, 2026, p. 249, https://doi.org/10.1016/j.clml.2026.01.015.